Clinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer’s disease receiving donepezil

Clinical trials have shown the benefits of acetylcholinesterase inhibitors, such as donepezil and galantamine, and an N-methyl-D-aspartate receptor antagonist, memantine, in patients with Alzheimer’s disease (AD). However, little is known regarding the effects of switching from donepezil 5 mg/day to...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Kano, Osamu, Ito, Hirono, Takazawa, Takanori, Kawase, Yuji, Murata, Kiyoko, Iwamoto, Konosuke, Nagaoka, Tetsuro, Hirayama, Takehisa, Miura, Ken, Nagata, Riya, Kiyozuka, Tetsuhito, Aoyagi, Jo, Sato, Ryuta, Eguchi, Teruo, Ikeda, Ken, Iwasaki, Yasuo
Формат: Artigo
Язык:Inglês
Опубликовано: Dove Medical Press 2013
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3575212/
https://ncbi.nlm.nih.gov/pubmed/23431041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S40682
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы